- Open
- 5.95
- High
- 6.20
- Low
- 5.73
- Close
- 6.20
- Change
- -0.25 (-4.20%)
- Volume
- 36,063
⌘K
| 2 Jun 2026 | 07:00:06 | Investor presentation and SweetBiotix® Sampling |
| 29 May 2026 | 07:00:04 | Director/PDMR Shareholding |
| 28 May 2026 | 07:00:03 | Final Results & Notice of AGM |
| 14 May 2026 | 07:00:07 | SweetBiotix® Sampling |
| 8 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 14 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
OptiBiotix Health is a biotech firm that focuses on cutting-edge research and development. Our primary focus is on preventing and treating chronic lifestyle diseases such as obesity, high cholesterol, lipid profiles, and diabetes.
| 2 Jun 2026 | 07:00:06 | Investor presentation and SweetBiotix® Sampling |
| 29 May 2026 | 07:00:04 | Director/PDMR Shareholding |
| 28 May 2026 | 07:00:03 | Final Results & Notice of AGM |
| 14 May 2026 | 07:00:07 | SweetBiotix® Sampling |
| 8 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 14 Jul 2023 | Annual Report and Accounts (to 2022-12-31) |
OptiBiotix Health is a biotech firm that focuses on cutting-edge research and development. Our primary focus is on preventing and treating chronic lifestyle diseases such as obesity, high cholesterol, lipid profiles, and diabetes.
| 5 May 2026 |
| 14:30:19 |
| Holding(s) in Company |
| 14 May 2026 |
| Market movers: Cisco Systems, Ideal Power, Snail, Klarna… |
| 14 May 2026 | AIM movers: TheraCryf progresses towards Ox-1 phase 1 trial and ex-dividends |
| 14 May 2026 | OptiBiotix shares surge 13.5% as company plans SweetBiotix showcase for investors |
| 5 May 2026 |
| 14:30:19 |
| Holding(s) in Company |
| 14 May 2026 |
| Market movers: Cisco Systems, Ideal Power, Snail, Klarna… |
| 14 May 2026 | AIM movers: TheraCryf progresses towards Ox-1 phase 1 trial and ex-dividends |
| 14 May 2026 | OptiBiotix shares surge 13.5% as company plans SweetBiotix showcase for investors |